IACM 2nd Conference on Cannabinoids in Medicine

Expert Opinion on Pharmacotherapy

Volumn 4, Issue 12, 2003, Pages 2367-2371

  Grotenhermen, Franjo ^a   Müller Vahl, Kirsten ^b  

^a Nova Institut GmbH   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Adverse effects; Basic research; Cannabinoids; Cannabis; Circulation; Endocannabinoids; HIV; Neurology; Neuroprotection; Pain; Schizophrenia; THC; Therapeutic use

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; ANTINEOPLASTIC AGENT; CANNABIDIOL; CANNABINOID; CANNABINOID DERIVATIVE; DRONABINOL; IMIPRAMINE; OPIATE; PLACEBO;

ANHEDONIA; ANOREXIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CANCER PAIN; CANNABIS ADDICTION; CHRONIC PAIN; CLINICAL RESEARCH; CLINICAL TRIAL; COGNITIVE DEFECT; CONTINUING EDUCATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE COURSE; DRUG INDICATION; DRUG USE; ENTERITIS; EXPERIENCE; FATIGUE; HEART INFARCTION; HUMAN; INFLAMMATION; INTERPERSONAL COMMUNICATION; MALIGNANT NEOPLASTIC DISEASE; MOUSE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NEUROLOGY; NEUROPATHIC PAIN; NEUROPROTECTION; NIGHT VISION; NONHUMAN; OSSIFICATION; OSTEOPOROSIS; PSYCHIATRY; PSYCHOSIS; RAT; RHEUMATOID ARTHRITIS; SCHIZOPHRENIA; SPASTICITY; SPINAL CORD INJURY; TREATMENT OUTCOME; VOMITING; WASTING SYNDROME; WORKSHOP; XEROSTOMIA;

CANNABINOIDS; HUMANS;

EID: 0346996611     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.4.12.2367     Document Type: Article

References (20)

1. GROTENHERMEN F: Pharmacokinetics and pharmacodynamics of cannabinoids. Clin. Pharmacokin. (2003) 42(4):327-360.
2. PERTWEE RG, ROSS RA: Cannabinoid receptors and their ligands. Prostaglandins Leukot. Essent. Fatty Acids (2002) 66(2-3):101-121.
3. MECHOULAM R. The role of the cannabinoid system in neuroprotection. Proceedings of the IACM 2nd Conference on Cannabinoids in Medicine, Cologne, Germany (2003):12.
4. DI MARZO V, BIFULCO M: Possible use of endocannabinoid-based therapeutic drugs against tumour growth and metastatic spreading. Proceedings of the IACM 2nd Conference on Cannabinoids in Medicine, Cologne, Germany (2003):25.
5. WAGNER J: Effects of endogenous cannabinoids on circulation. Proceedings of the IACM 2nd Conference on Cannabinoids in Medicine, Cologne, Germany (2003):15.
6. FORD WR, HILEY CR. Anandamide limits infarction after ischemia-reperfusion in rat isolated hearts. Proceedings of the IACM 2nd Conference on Cannabinoids in Medicine, Cologne, Germany (2003):9.
7. FRIDE E, FEIGIN C, PONDE D, BREUERA, HANUš L, MECHOULAM R: Effects of cannabidiol analogues on intestinal motility: possible application for inflammatory bowel disease. Proceedings of the IACM 2nd Conference on Cannabinoids in Medicine, Cologne, Germany (2003):8.
8. MECHOULAM R, BAB I: Cannabinoids and bone remodeling. Proceedings of the IACM 2nd Conference on Cannabinoids in Medicine, Cologne, Germany (2003):16.
9. 9-tetrahydrocannabinol, and cannabichromene extracts alter behavioral despair on the mouse tail supension test of depression. Proceedings of the IACM 2nd Conference on Cannabinoids in Medicine, Cologne, Germany (2003):30.
10. HAGENBACH U, LUZ S, BRENNEISEN R, MÄDER M: The treatment of spasticity with D9-tetrahydrocannabinol (D9-THC) in patients with spinal cord injury. Proceedings of the IACM 2nd Conference on Cannabinoids in Medicine, Cologne, Germany (2003):5.
11. ZAJICEK J, FOX P, SANDERS M et al.: The use of cannabinoids for the treatment of spasticity and other symptoms related to multiple sclerosis - results of a multicentre randomised placebo-controlled trial (the CAMS study). Lancet (2003) (In Press).
12. ABRAMS DI, JAY C, PETERSEN K et al: The effects of smoked cannabis in painful peripheral neuropathy and cancer pain refractory to opioids. Proceedings of the IACM 2nd Conference on Cannabinoids in Medicine, Cologne, Germany (2003):28.
13. HOLDCROFT A, MAZE M, TEBBS S, DORÉ C: An escalating dose study of cannador for postoperative pain: dose related effects. Proceedings of the IACM 2nd Conference on Cannabinoids in Medicine, Cologne, Germany (2003):27.
14. HELWIG S, FRONK EM, REIF M, SCHNELLE M, HOFFMANN J: Maximally tolerated dose (MTD) of standardized cannabis extract in palliative cancer patients: preliminary results from an open-label, non-randomized Phase I/II trial. Proceedings of the IACM 2nd Conference on Cannabinoids in Medicine, Cologne, Germany (2003):21.
15. KARST M, SALIM K, BURSTEIN S, CONRAD I, HOY L, SCHNEIDER U: Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial. JAMA (2003) 290(13):1757-1762.
16. RUSSO E, MERZOUKI A, MOLERO MESA J, FREY K: Cannabis improves night vision: a pilot study of visual threshold and dark adaptometry in kif smokers in the Rif region in northern Morocco. Proceedings of the IACM 2nd Conference on Cannabinoids in Medicine, Cologne, Germany (2003):17.
17. LEWEKE FM, GIUFFRIDA A, GERTH CW et al.: Endogenous cannabinoids and their role in psychiatric disorders. Proceedings of the IACM 2nd Conference on Cannabinoids in Medicine, Cologne, Germany (2003):29.
18. SCHNEIDER M, KOCH M: Chronic peripubertal cannabinoid treatment leads to behavioural disturbances in adult rats. Proceedings of the IACM 2nd Conference on Cannabinoids in Medicine, Cologne, Germany (2003):33.
19. FRIED P, GRAY R, WATKINSON B: Does sex matter? A within- and between-subject longitudinal assessment of marihuana's impact and memory and processing speed. Proceedings of the IACM 2nd Conference on Cannabinoids in Medicine, Cologne, Germany (2003):19.
20. GROTENHERMEN F, RUSSO E (Eds): Cannabis and cannabinoids. Pharmacology, toxicology, and therapeutic potential. Haworth Press, Binghamton, NY, USA (2002).